Target intelligence / Profile preview

Sodium-dependent vitamin C transporter 1 (for SVCT1) and Sodium-dependent vitamin C transporter 2 (for SVCT2) (SVCT1 (SLC23A1), SVCT2 (SLC23A2))

Target
SVCT1 (SLC23A1), SVCT2 (SLC23A2)
Molecular classification
Transporter, Solute carrier family (SLC23), Nucleobase-ascorbate transporter (NAT) family, Membrane protein
01

Overview

Sodium-dependent vitamin C transporters are integral membrane proteins responsible for the active uptake of vitamin C (ascorbic acid) into cells, essential for human health because humans cannot synthesize vitamin C. The two main isoforms, SVCT1 (encoded by *SLC23A1*) and SVCT2 (encoded by *SLC23A2*), are members of the nucleobase-ascorbate transporter (NAT) family within the solute carrier (SLC23) superfamily[1][2][3][4][6]. These transporters co-transport sodium and vitamin C in a 2:1 stoichiometry, using the sodium gradient across the plasma membrane to drive the uptake of ascorbate against its concentration gradient[1][3][4][5]. SVCT1 is primarily involved in vitamin C absorption and re-absorption in epithelial tissues such as intestine and kidney, controlling systemic levels[1][2][4][7]. SVCT2 is widely expressed, facilitating vitamin C uptake in tissues with high metabolic needs such as brain and placenta[1][2][4]. In contrast, the oxidized form of vitamin C (dehydroascorbic acid) is taken up via glucose transporters (GLUT1, GLUT3, and GLUT4)[2][6]. Dysfunction or genetic variation in these transporters can impair vitamin C bioavailability and increase risk for diseases associated with oxidative stress, metabolic disorders, neurological deficits, and certain cancers[7][8]. Currently, no therapeutic inhibitors or activators are in clinical use, but transporter expression can affect efficacy of pharmacological vitamin C therapy[7][8].

Other names
SVCT1 (SLC23A1), sodium-ascorbate co-transporter 1SVCT2 (SLC23A2), sodium-ascorbate co-transporter 2Sodium-dependent vitamin C transporter familyNucleobase-ascorbate transporter family (as broader family)Vitamin C transporter (generic)
02

Mechanism of action

Symport/co-transport: vectorial uptake of vitamin C (ascorbic acid) together with sodium ions (2:1 Na+:ascorbate)[1][3][4]; Transport of reduced ascorbic acid (not dehydroascorbic acid, which is transported by GLUTs)[2][6]

03

Biological functions

Uptake and tissue distribution of vitamin C (ascorbic acid)Maintenance of whole-body vitamin C homeostasisAntioxidant defense (by providing ascorbate for neutralizing oxidative stress)Support of enzymatic reactions requiring vitamin C as cofactor (e.g., collagen synthesis, neurotransmitter biosynthesis, carnitine synthesis)[2][6]
04

Disease associations

Cancer (polymorphisms linked to cancer susceptibility and tumor biology)[7]Neurological disorders (due to requirement of vitamin C for neuronal function)[2]Metabolic diseases (due to deficiency or transport dysfunction)[8]Scurvy (vitamin C deficiency)[2]Other (as related to tissue-specific vitamin C demands)
05

Safety considerations

Polymorphisms in *SLC23A1* or *SLC23A2* can affect plasma/tissue ascorbate levels, influencing susceptibility to disease or drug efficacy[7]No major on-target safety issues directly due to transporter modulation are documented, but impaired function results in deficiencyTransporters may be saturated at high doses, limiting bioavailability of oral vitamin C
06

Interacting drugs

No clinically approved drugs directly target SVCTs for inhibition or modulation as of 2025.

1 more in the full profile.

07

Biomarkers

SVCT1 or SVCT2 gene/protein expression levels (e.g., *SLC23A1*, *SLC23A2* mRNA/protein as proxies for vitamin C uptake capacity)[7]

Beyond the preview

Go deeper on Sodium-dependent vitamin C transporter 1 (for SVCT1) and Sodium-dependent vitamin C transporter 2 (for SVCT2) (SVCT1 (SLC23A1), SVCT2 (SLC23A2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent vitamin C transporter 1 (for SVCT1) and Sodium-dependent vitamin C transporter 2 (for SVCT2) (SVCT1 (SLC23A1), SVCT2 (SLC23A2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call